Free Newsletter
DelBello draws added scrutiny for undisclosed funds
University of Cincinnati researcher Melissa DelBello is getting some added scrutiny after finding herself in Senator Charles Grassley's crosshairs. Grassley (R-IA) chastised the researcher for failing to disclose large sums of money she received from AstraZeneca a year after completing a study of Seroquel for bipolar disease. Grassley also criticized AstraZeneca's undisclosed financial ties to a company DelBello formed. DelBello will now be required to review all the money she has received from AstraZeneca in the last decade and will review all her financial ties to outside companies.
- check out the report in the Cincinnati Enquirer
Related Articles:
Seroquel researcher got cash from AZ. Fund report
Arms twisted, pharma promises disclosure. Disclosure report
Senate investigates pharma influence on CME. Senate report
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceBiotech Research email newsletter for FREE!
Be the first to comment